Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
29.06
+0.55 (1.93%)
Sep 29, 2026, 9:57 AM EDT - Market open

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,6382,4798857091,0933,960
Market Cap Growth
130.39%180.23%24.72%-35.07%-72.41%-51.03%
Enterprise Value
4,6772,4768425697983,441
Last Close Price
28.5116.246.004.907.6428.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.778.954.944.175.9025.66
PB Ratio
31.7311.024.372.302.356.56
P/TBV Ratio
197.3325.2711.023.853.238.31

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.898.944.703.344.3122.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.730.941.100.740.500.19
Net Debt / Equity Ratio
0.26-0.13-0.16-0.38-0.57-0.76
Net Debt / EBITDA Ratio
-1.820.760.250.651.482.35
Net Debt / FCF Ratio
-1.610.610.340.701.321.80
Asset Turnover
0.540.530.300.220.210.15
Inventory Turnover
17.3018.0915.3013.6811.8411.50
Quick Ratio
4.513.102.714.384.913.27
Current Ratio
4.803.342.894.665.123.54
Return on Equity (ROE)
-38.76%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-4.12%-6.79%-16.18%-16.60%-14.06%-12.81%
Return on Capital Employed (ROCE)
-6.80%-13.50%-35.20%-35.20%-26.80%-25.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.40%-2.40%-18.03%-31.75%-18.32%-5.23%
FCF Yield
-0.53%-1.97%-11.18%-23.54%-18.33%-6.43%
Buyback Yield / Dilution
-4.11%-3.14%-1.88%-1.31%-1.54%-6.96%
SEC Filings: 10-K · 10-Q